Bank of America’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.2M | Buy |
1,043,159
+535,649
| +106% | +$6.08M | ﹤0.01% | 2741 |
|
|
2025
Q4 | $4.15M | Buy |
507,510
+404,060
| +391% | +$4.65M | ﹤0.01% | 3532 |
|
|
2025
Q3 | $1.24M | Sell |
103,450
-194,992
| -65% | -$2.05M | ﹤0.01% | 5173 |
|
|
2025
Q2 | $3.03M | Buy |
298,442
+38,641
| +15% | +$259K | ﹤0.01% | 4382 |
|
|
2025
Q1 | $1.45M | Buy |
259,801
+147,281
| +131% | +$1.29M | ﹤0.01% | 4958 |
|
|
2024
Q4 | $908K | Buy |
112,520
+28,570
| +34% | +$262K | ﹤0.01% | 5110 |
|
|
2024
Q3 | $860K | Sell |
83,950
-192,539
| -70% | -$1.9M | ﹤0.01% | 5153 |
|
|
2024
Q2 | $1.95M | Buy |
276,489
+75,367
| +37% | +$675K | ﹤0.01% | 4459 |
|
|
2024
Q1 | $2.77M | Buy |
201,122
+95,432
| +90% | +$1.13M | ﹤0.01% | 4187 |
|
|
2023
Q4 | $972K | Sell |
105,690
-27,416
| -21% | -$198K | ﹤0.01% | 5001 |
|
|
2023
Q3 | $805K | Sell |
133,106
-12,445
| -9% | -$102K | ﹤0.01% | 4976 |
|
|
2023
Q2 | $1.13M | Buy |
145,551
+20,314
| +16% | +$115K | ﹤0.01% | 4683 |
|
|
2023
Q1 | $714K | Buy |
125,237
+92,457
| +282% | +$483K | ﹤0.01% | 5133 |
|
|
2022
Q4 | $193K | Buy |
32,780
+3,262
| +11% | +$11K | ﹤0.01% | 5932 |
|
|
2022
Q3 | $95K | Buy |
29,518
+4,661
| +19% | +$18.7K | ﹤0.01% | 6370 |
|
|
2022
Q2 | $111K | Sell |
24,857
-5,484
| -18% | -$21.9K | ﹤0.01% | 6419 |
|
|
2022
Q1 | $162K | Sell |
30,341
-47,522
| -61% | -$428K | ﹤0.01% | 6592 |
|
|
2021
Q4 | $1.15M | Buy |
77,863
+64,889
| +500% | +$1.01M | ﹤0.01% | 5103 |
|
|
2021
Q3 | $271K | Sell |
12,974
-6,840
| -35% | -$139K | ﹤0.01% | 6086 |
|
|
2021
Q2 | $351K | Buy |
19,814
+9,515
| +92% | +$209K | ﹤0.01% | 5688 |
|
|
2021
Q1 | $252K | Buy |
10,299
+7,646
| +288% | +$242K | ﹤0.01% | 5870 |
|
|
2020
Q4 | $89K | Buy |
2,653
+1,002
| +61% | +$28.7K | ﹤0.01% | 6046 |
|
|
2020
Q3 | $41K | Sell |
1,651
-11,709
| -88% | -$279K | ﹤0.01% | 6090 |
|
|
2020
Q2 | $451K | Buy |
+13,360
| New | +$426K | ﹤0.01% | 4693 |
|
Other funds holding ORIC
NI
EC
SOCM
P
VA
NMC